Cerebras vs Nvidia Stock 2026: Should You Buy CBRS? Find Your AI Chip Investor Type

# Cerebras vs Nvidia Stock 2026: Should You Buy CBRS? Find Your AI Chip Investor Type

> **Quick answer:** Whether to buy Cerebras (CBRS) vs Nvidia depends on your risk profile. Cerebras popped 68% on its IPO debut — pricing at $185, closing Day 1 at $311 — but trades at ~130x trailing sales with 62% customer concentration in a single UAE institution. Nvidia generates $215.9B annually with a 15-year software moat. The five AI chip investor types are: The Cerebras Contrarian, The Nvidia Loyalist, The ETF Diversifier, The Wait-for-Lockup, and The AI Skeptic. Take the quiz below to find yours.

Cerebras Systems made its Nasdaq debut on May 14, 2026, and the AI chip world has been arguing about it ever since. The stock priced at $185, opened at $385, and closed at $311 — a 68% first-day gain that valued the company at roughly $95 billion on just $510 million in annual revenue. That is a 130x price-to-sales multiple. That is also the highest-profile AI chip IPO since Nvidia went public in 1999.

The question investors are now wrestling with is not whether Cerebras has interesting technology — it does. The Wafer Scale Engine 3 benchmarks at 21x faster for AI inference tasks compared to Nvidia's DGX B200, at 32% lower total cost of ownership. The OpenAI partnership reportedly involves contracts worth over $20 billion. Revenue grew 76% year-over-year to $510 million in 2025.

The question is: does any of that justify buying CBRS at current prices, and what kind of investor are you if you do — or don't?

## The Cerebras vs Nvidia Stock Decision Framework